Peak Health Won the Yangtze River Delta "Demonstration Factory"
Release time:
2020-08-14
Peak Health Won Yangtze River Delta "Demonstration Factory"
News # July 20 On the evening of 2017 , the award ceremony of "Yangtze River Delta Nutrition and Health Industry Selection" was held in Shanghai, and Peak Health Technology Co., Ltd. was awarded the "Demonstration Factory" award.
This selection activity is organized and carried out by the Yangtze River Delta Nutrition and Health Care Industry Alliance. It aims to establish a model force for the Yangtze River Delta health industry, further promote the development of the health industry, and boost the people's confidence in health industry enterprises, products and service capabilities. This selection activity is voluntarily declared by enterprises, recommended by alliance member units and cooperative units to determine the list of candidates. After preliminary qualification review, expert review, online voting, public announcement and other links, the selection principle of "open, fair, transparent and comprehensive" is followed; set up the "Demonstration Factory Award", "Technology Innovation Award", "Health Industry Special Award", "Health Leading Award", "Excellent Service Provider Award", "Craftsman Award", "Outstanding Social Responsibility Award", "Excellent Taiwan Product Award" and other awards. Spike health by the Zhejiang Province Health Products Cosmetics Association recommended to participate in the selection.
China Health Care Association, Zhejiang Health Products Cosmetics Industry Association, Taiwan Health Care Alliance Association, Jiangxi Nutrition and Health Food Cosmetics Association, Jiangsu Health Care Industry Association, China Food Fermentation Institute Industry Research Institute and other well-known social organizations and leaders of research institutions attended the award ceremony on the evening of 20 . Chen daiyou, general manager of peak health, took the stage to receive the medal of "demonstration factory.
In order to vigorously promote outstanding enterprises and products and expand the influence of award-winning enterprises and individuals, in addition to awarding awards and commendations, the 8th China International Health Products Exhibition, 2017 Asian Natural and Nutritional Health Products Exhibition, held in Shanghai on 6 20 -22 , the "Yangtze River Delta Nutrition and Health Care Alliance Characteristic Industry Pavilion" was specially set up to display the award-winning enterprises and related products, and the list was published on the spot in the series of activities of the Yangtze River Delta Nutrition and Health Care Industry Alliance held by the Shanghai New International Expo Center for publicity. Obtaining the honor of "demonstration factory" in the nutrition and health care industry in the Yangtze River Delta has not only improved the image and product popularity of Jianfeng Health Company, but also expanded the influence of the company in the industry. (Wang Bingbing)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page